Lopinavir/r versus nelfinavir as salvage therapy

被引：1
|
作者：
Resino, S [1 ]
Alvaro-Meca, A
de José, MI
Gurbindo, MD
Ramos, JT
Martin-Fontelos, P
Muñoz-Fernández, MA
机构：
[1] Hosp Gregorio Maranon, Lab Immuno Biol Mol, Madrid, Spain
[2] Hosp La Paz, Serv Pediat, La Paz, Bolivia
[3] Hosp Gregorio Maranon, Serv Inmuno Pediat, Madrid, Spain
[4] Hosp Carlos III, Serv Pediat Infecc, Madrid, Spain
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2005年 / 24卷 / 04期
关键词：
D O I：
10.1097/01.inf.0000157922.19139.90
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：392 / 393
页数：2
相关论文
共 50 条
  • [41] Week 96 Efficacy, Virology and Safety of Darunavir/r Versus Lopinavir/r in Treatment-Experienced Patients in TITAN
    Banhegyi, Denes
    Katlama, Christine
    da Cunha, Clovis Arns
    Schneider, Stefan
    Rachlis, Anita
    Workman, Cassy
    De Meyer, Sandra
    Vandevoorde, Ann
    Van de Casteele, Tom
    Tomaka, Frank
    CURRENT HIV RESEARCH, 2012, 10 (02) : 171 - 181
  • [42] COST EFFECTIVENESS OF SWITCHING TO SECOND LINE THERAPY WITH LOPINAVIR/RITONAVIR (LPV/R) IN KENYA
    Simpson, K. N.
    Dietz, B.
    Rahim, S.
    Rajagopalan, R.
    VALUE IN HEALTH, 2009, 12 (03) : A116 - A116
  • [43] Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy
    Vesterbacka, Jan
    Nowak, Piotr
    Barqasho, Babilonia
    Abdurahman, Samir
    Nystrom, Jessica
    Nilsson, Staffan
    Funaoka, Hiroyuki
    Kanda, Tatsuo
    Andersson, Lars-Magnus
    Gisslen, Magnus
    Sonnerborg, Anders
    PLOS ONE, 2013, 8 (01):
  • [44] Cost-effectiveness of lopinavir/ritonavir compared to nelfinavir as first-line antiretroviral therapy in treatment naive HIV patients: A managed care perspective
    Luo, MP
    Botteman, MF
    Grad, O
    Cifaldi, MA
    Ashraf, T
    VALUE IN HEALTH, 2003, 6 (03) : 265 - 265
  • [45] Adjuvant Radiation Therapy versus early Salvage Radiation Therapy after radical Prostatectomy
    Lenzen, J.
    Feldmann, H. J.
    ONKOLOGE, 2021, 27 (06): : 610 - 612
  • [46] Postoperative Proton Therapy for Chordomas and Chondrosarcomas of the Spine Adjuvant Versus Salvage Radiation Therapy
    Holliday, Emma B.
    Mitra, Hari S.
    Somerson, Jeremy S.
    Rhines, Laurence D.
    Mahajan, Anita
    Brown, Paul D.
    Grosshans, David R.
    SPINE, 2015, 40 (08) : 544 - 549
  • [47] Therapeutic drug monitoring of the HIV/AIDS drugs abacavir, zidovudine, efavirenz, nevirapine, indinavir, lopinavir, and nelfinavir
    Donnerer, J
    Kronawetter, M
    Kapper, A
    Haas, I
    Kessler, HH
    PHARMACOLOGY, 2003, 69 (04) : 197 - 204
  • [48] Carbamazepine interactionFirst report of an interaction with concomitant lopinavir/ritonavir and nelfinavir leading to various toxicities: case report
    Reactions Weekly, 2006, 1107 (1) : 9 - 9
  • [49] Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir
    McCance-Katz, Elinore F.
    Moody, David E.
    Smith, Patrick F.
    Morse, Gene D.
    Friedland, Gerald
    Pade, Patricia
    Baker, Jennifer
    Alvanzo, Anika
    Jatlow, Peter
    Rainey, Petrie M.
    CLINICAL INFECTIOUS DISEASES, 2006, 43 : S235 - S246
  • [50] THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
    PARKER, PM
    CHAO, N
    NADEMANEE, A
    ODONNELL, MR
    SCHMIDT, GM
    SNYDER, DS
    STEIN, AS
    SMITH, EP
    MOLINA, A
    STEPAN, DE
    KASHYAP, A
    PLANAS, I
    SPIELBERGER, R
    SOMLO, G
    MARGOLIN, K
    ZWINGENBERGER, K
    WILSMAN, K
    NEGRIN, RS
    LONG, GD
    NILAND, JC
    BLUME, KG
    FORMAN, SJ
    BLOOD, 1995, 86 (09) : 3604 - 3609
12345